معرفی
Stephen O'Rahilly is a Professor of Clinical Biochemistry and Medicine at the University of Cambridge. He serves as Director of the MRC Metabolic Diseases Unit, Co-Director of the Wellcome-MRC Institute of Metabolic Science, and Associate Faculty Member at the Wellcome Sanger Institute. His research focuses on molecular mechanisms underlying obesity, insulin resistance, and Type 2 diabetes.
- Professor of Clinical Biochemistry and Medicine (2002–present)
- Director, MRC Metabolic Diseases Unit (2013–present)
- Co-Director, Wellcome-MRC Institute of Metabolic Science (2013–present)
- Scientific Director, NIHR Cambridge Biomedical Research Centre (2011–present)
Research Interests: O'Rahilly investigates genetic and molecular causes of metabolic disorders, particularly obesity and diabetes. His work bridges fundamental discoveries in human genetics with translational applications for improved patient diagnosis and therapies. Key contributions include identifying novel genetic drivers of metabolic diseases and developing clinical research infrastructure in Cambridge.
Scientific Recognition: His accolades include multiple international awards such as the Banting Medal for Scientific Achievement, Helmholtz Diabetes Award, and Royal Society Croonian Medal. He is a Fellow of the Royal Society and EMBO member, with five honorary doctorates.
- Royal Society Fellow (2003)
- EMBO Member (2009)
- US National Academy of Sciences Member (2011)
Mentorship & Service: As a Knight Bachelor (2013) and Pembroke College Fellow (2007–present), O'Rahilly mentors young scientists and serves on advisory boards across academia, government, and industry. He contributes editorially to leading journals and advances biomedical research infrastructure.
